Home›Water Soluble Intravenous Radiographic Contrast Agents›Water Soluble Intravenous Radiographic Contrast Agents + Sodium Iodide I 131

Does Water Soluble Intravenous Radiographic Contrast Agents Interact with Sodium Iodide I 131?

Moderate interaction. Radiographic contrast agent that interferes with radioiodide accumulation. Discontinue 2 months before procedure.

Source & how this summary was prepared

This interaction summary was extracted from FDA drug labeling through openFDA, using automated processing and AI assistance. NIH/NLM RxNorm helps organize drug names.

Read the saved source label on DailyMed →

A separate current-label comparison has not been recorded for this page. Read about our extraction process.

Interaction classification: Moderate
Management: Confirm exact products with your pharmacist
Data Source: U.S. FDA via OpenFDA

How this interaction works

Blocks radioiodine uptake

What To Tell Your Doctor or Pharmacist

If you are taking Water Soluble Intravenous Radiographic Contrast Agents and your doctor is considering prescribing Sodium Iodide I 131 (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Ask whether any dosage adjustments are needed
Never stop or change either medication without first consulting your healthcare provider

💊 Water Soluble Intravenous Radiographic Contrast Agents+💊 Sodium Iodide I 131(Sodium Iodide I 131 Diagnostic)

Severity & Interaction Details

🟡

moderate

Moderate interaction

Read the interaction summary and source below. Use this information to discuss your medication list with your care team.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

—

Source

NLP:sodium iodide i 131

What this means in plain English

Radiographic contrast agent that interferes with radioiodide accumulation. Discontinue 2 months before procedure.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:sodium iodide i 131

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

FDA Safety Alert: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acellaabout Water Soluble Intravenous Radiographic Contrast Agents · 2026-05

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check the medicines you actually take

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

FDA data. NIH drug identities. Plain-language explanations by CDI. Prepared with automated extraction and AI assistance; curated references are identified separately. How we prepare the information · Suggest a correction

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.